InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
2
T+90 hit rate
100%
T+90 mean return
+10.3%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Susman Robert Graham, Director. Director active across 1 company, notably Immunovant, Inc.. In total, 3 disclosures have been logged. Breakdown: 0 buy · 2 sells. Total volume traded: €116k. History available since 1 May 2025. The latest transaction was filed on 1 May 2026 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations3 total
2,502 shares@ US$27.170.0010% mcap50.0% of flowCommon StockSEC:0001764013-26-000058:0
2,502 shares@ US$27.170.0010% mcap50.0% of flowCommon StockSEC:0001764013-26-000058
25,016 shares0Common StockSEC:0001415889-25-012045:0
3 of 3 declarations
About Susman Robert Graham
Robert Graham Susman is a Director at Immunovant, Inc. He brings his expertise in strategy and corporate governance to the board. Robert is involved in overseeing the company's performance and providing strategic direction for business initiatives. His experience in the pharmaceutical sector enables him to contribute effectively to discussions and decision-making at Immunovant.
